Clinical Contrasting Observation on Therapeutic Effect of Xuezhikang Capsules and Lovastatins
Yu-ling Ge
Abstract
Yu-ling Ge
Abstract
Objective To evaluate the curative effect of Xuezhikang Capsules. Methods 92 cases of primary hyperlipidemia were randomly separated into experiment group and control group, Members in the experiment group were treated by Xuezhikang Capsules with 2 granules for one time and twice daily, lasting for 8 weeks. Members in the control group were treated by lovastatins after supper with 20mg for one time and once daily, lasting for 8 weeks, too. At the end of therapeutic courses, clinical efficacy of blood fat controlling was evaluated. Results There was no significant difference (P>0.05 )between the two groups in terms of blood fat improvement and total effective rate. Conclusion Xuezhikang Capsules was effective in controlling hyperlipidemia. Key words: Xuezhikang Capsules; Lovastatins; Biood-fat control
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To evaluate the curative effect of Xuezhikang Capsules. Methods 92 cases of primary hyperlipidemia were randomly separated into experiment group and control group, Members in the experiment group were treated by Xuezhikang Capsules with 2 granules for one time and twice daily, lasting for 8 weeks. Members in the control group were treated by lovastatins after supper with 20mg for one time and once daily, lasting for 8 weeks, too. At the end of therapeutic courses, clinical efficacy of blood fat controlling was evaluated. Results There was no significant difference (P>0.05 )between the two groups in terms of blood fat improvement and total effective rate. Conclusion Xuezhikang Capsules was effective in controlling hyperlipidemia. Key words: Xuezhikang Capsules; Lovastatins; Biood-fat control
Key concepts: Hyperlipidemia, Medicine, Therapeutic effect, Blood lipids, Significant difference, Internal medicine, Postprandial, Gastroenterology